Abstract:Background: Osteoporosis and osteopenia are often undiagnosed until fragility fractures occur. Dual-energy X-ray absorptiometry (DXA) is the reference standard for bone mineral density (BMD) assessment, but access remains limited. Knee radiographs are obtained at high volume for osteoarthritis evaluation and may offer an opportunity for opportunistic bone-loss screening. Objective: To develop and evaluate a multi-task deep learning system for opportunistic bone-loss screening from routine knee radiographs without additional imaging or patient visits. Methods: We developed STR-Net, a multi-task framework for single-channel grayscale knee radiographs. The model includes a shared backbone, global average pooling feature aggregation, a shared neck, and a task-aware representation routing module connected to three task-specific heads: binary screening (Normal vs. Bone Loss), severity sub-classification (Osteopenia vs. Osteoporosis), and weakly coupled T-score regression with optional clinical variables. A sensitivity-constrained threshold optimization strategy (minimum sensitivity >= 0.86) was applied. The dataset included 1,570 knee radiographs, split at the patient level into training (n=1,120), validation (n=226), and test (n=224) sets. Results: On the held-out test set, STR-Net achieved an AUROC of 0.933, sensitivity of 0.904, specificity of 0.773, and AUPRC of 0.956 for binary screening. Severity sub-classification achieved an AUROC of 0.898. The T-score regression branch showed a Pearson correlation of 0.801 with DXA-measured T-scores in a pilot subset (n=31), with MAE of 0.279 and RMSE of 0.347. Conclusions: STR-Net enables single-pass bone-loss screening, severity stratification, and quantitative T-score estimation from routine knee radiographs. Prospective clinical validation is needed before deployment.
Abstract:Automated Kellgren--Lawrence (KL) grading from knee radiographs is challenging due to subtle structural changes, long-range anatomical dependencies, and ambiguity near grade boundaries. We propose AGE-Net, a ConvNeXt-based framework that integrates Spectral--Spatial Fusion (SSF), Anatomical Graph Reasoning (AGR), and Differential Refinement (DFR). To capture predictive uncertainty and preserve label ordinality, AGE-Net employs a Normal-Inverse-Gamma (NIG) evidential regression head and a pairwise ordinal ranking constraint. On a knee KL dataset, AGE-Net achieves a quadratic weighted kappa (QWK) of 0.9017 +/- 0.0045 and a mean squared error (MSE) of 0.2349 +/- 0.0028 over three random seeds, outperforming strong CNN baselines and showing consistent gains in ablation studies. We further outline evaluations of uncertainty quality, robustness, and explainability, with additional experimental figures to be included in the full manuscript.
Abstract:Knee osteoarthritis (KOA) grading based on radiographic images is a critical yet challenging task due to subtle inter-grade differences, annotation uncertainty, and the inherently ordinal nature of disease progression. Conventional deep learning approaches typically formulate this problem as deterministic multi-class classification, ignoring both the continuous progression of degeneration and the uncertainty in expert annotations. In this work, we propose ClinNet, a novel trustworthy framework that addresses KOA grading as an evidential ordinal regression problem. The proposed method integrates three key components: (1) a Bilateral Asymmetry Encoder (BAE) that explicitly models medial-lateral structural discrepancies; (2) a Diagnostic Memory Bank that maintains class-wise prototypes to stabilize feature representations; and (3) an Evidential Ordinal Head based on the Normal-Inverse-Gamma (NIG) distribution to jointly estimate continuous KL grades and epistemic uncertainty. Extensive experiments demonstrate that ClinNet achieves a Quadratic Weighted Kappa of 0.892 and Accuracy of 0.768, statistically outperforming state-of-the-art baselines (p < 0.001). Crucially, we demonstrate that the model's uncertainty estimates successfully flag out-of-distribution samples and potential misdiagnoses, paving the way for safe clinical deployment.